These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20527380)

  • 1. [Natriuretic peptides: anything new in cardiology?].
    Malinowski M; Biernat J; Roleder T; Dalecka AM; Reszka B; Deja MA; Wośf S; Gołba KS
    Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S578-85. PubMed ID: 20527380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of natriuretic peptides in cardioprotection.
    Nishikimi T; Maeda N; Matsuoka H
    Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides and remodeling in heart failure.
    Burnett JC
    Heart Fail Clin; 2005 Apr; 1(1):129-39. PubMed ID: 17386839
    [No Abstract]   [Full Text] [Related]  

  • 4. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
    Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M
    Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac natriuretic peptides: from basic discovery to clinical practice.
    Hayek S; Nemer M
    Cardiovasc Ther; 2011 Dec; 29(6):362-76. PubMed ID: 20433683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical implications of current natriuretic peptide research.
    Sagnella GA
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):304-15. PubMed ID: 11967816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natriuretic peptides.
    Baxter GF
    Basic Res Cardiol; 2004 Mar; 99(2):71-5. PubMed ID: 14963664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides and the dialysis patient.
    Suresh M; Farrington K
    Semin Dial; 2005; 18(5):409-19. PubMed ID: 16191182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms.
    Ahluwalia A; MacAllister RJ; Hobbs AJ
    Basic Res Cardiol; 2004 Mar; 99(2):83-9. PubMed ID: 14963666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and metabolic effects of natriuretic peptides.
    Moro C; Berlan M
    Fundam Clin Pharmacol; 2006 Feb; 20(1):41-9. PubMed ID: 16448393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine and paracrine actions of natriuretic peptides in the heart.
    D'Souza SP; Davis M; Baxter GF
    Pharmacol Ther; 2004 Feb; 101(2):113-29. PubMed ID: 14761702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
    Imura H; Nakao K; Itoh H
    Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.
    Kuwahara K
    Pharmacol Ther; 2021 Nov; 227():107863. PubMed ID: 33894277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the role of natriuretic peptides in the regulation of apoptosis in cardiovascular system.
    Gao P; Huang L
    Saudi Med J; 2009 May; 30(5):595-604. PubMed ID: 19417955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacologic therapies for acute heart failure.
    Tavares M; Rezlan E; Vostroknoutova I; Khouadja H; Mebazaa A
    Crit Care Med; 2008 Jan; 36(1 Suppl):S112-20. PubMed ID: 18158470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure.
    Del Ry S; Cabiati M; Lionetti V; Simioniuc A; Caselli C; Prescimone T; Emdin M; Giannessi D
    Peptides; 2009 Sep; 30(9):1710-3. PubMed ID: 19540894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.